Cerebral Oximetry During Awake Carotid Endarterectomy
NCT07816081
Anesthesia, Conduction, Arterial Occlusive Diseases
Hanoi, Phuongmai, Vietnam
View Trial DetailsNCT Number: NCT07843186
This prospective observational study aims to evaluate whether intraoperative venous-to-arterial carbon dioxide partial pressure difference (PCO₂ gap) and arterial lactate levels can serve as early predictors of postoperative cognitive dysfunction (POCD) in elderly patients undergoing elective cardiac surgery with cardiopulmonary bypass. Intraoperative measurements of PCO₂ gap and lactate will be correlated with perioperative cognitive outcomes assessed using the Montreal Cognitive Assessment (MoCA) and postoperative delirium screening using the Confusion Assessment Method for the ICU (CAM-ICU).
Trial opening soon.
Get Notified65 year and older
All sexes
Observational
This prospective observational cohort study will be conducted at El-Demerdash Hospital, Ain Shams University. Patients aged 65 years and older undergoing elective cardiac surgery with cardiopulmonary bypass will be enrolled. Serial measurements of the PCO₂ gap and arterial lactate will be obtained before induction, during CPB, at the end of CPB, 30 minutes after weaning from CPB, and immediately postoperatively. Cognitive function will be evaluated preoperatively and one month after surgery using the Montreal Cognitive Assessment (MoCA). Postoperative delirium will be assessed daily during ICU stay using CAM-ICU. The study will investigate the predictive value of intraoperative PCO₂ gap and lactate levels for postoperative cognitive dysfunction and determine potential cutoff values associated with cognitive decline.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Baseline (preoperative) and 1 month postoperatively
To evaluate whether intraoperative venous-to-arterial carbon dioxide partial pressure difference (PCO₂ gap) and arterial lactate levels predict postoperative cognitive dysfunction in elderly patients undergoing elective cardiac surgery with cardiopulmonary bypass. POCD will be assessed by changes in Montreal Cognitive Assessment (MoCA) scores from the preoperative baseline to 1 month postoperatively.
Time frame: Daily during the first 5 postoperative days or until ICU discharge, whichever occurs first
To determine the occurrence of early postoperative delirium using the Confusion Assessment Method for the ICU (CAM-ICU). CAM-ICU is a dichotomous assessment (positive or negative), where a positive result indicates the presence of delirium
Time frame: 1 month postoperative
To identify optimal cutoff values for intraoperative PCO₂ gap and arterial lactate levels associated with postoperative cognitive dysfunction in elderly patients undergoing cardiac surgery with cardiopulmonary bypass.The PCO₂ gap will be measured in mmHg, and arterial lactate concentration will be measured in mmol/L.
Time frame: CAM-ICU: Daily during the first 5 postoperative days; MoCA: baseline preoperatively and 1 month postoperatively
To evaluate the correlation between postoperative delirium assessed by the Confusion Assessment Method for the ICU (CAM-ICU) and postoperative cognitive function assessed by the Montreal Cognitive Assessment (MoCA).CAM-ICU will be recorded as a dichotomous result (positive or negative), with a positive result indicating the presence of delirium. MoCA will be recorded as a total score ranging from 0 to 30, with higher scores indicating better cognitive function
Time frame: Baseline (preoperative) and 1 month postoperatively
To determine the incidence of postoperative cognitive dysfunction, defined as a decline in MoCA score from the preoperative baseline, one month after cardiac surgery
Time frame: Measured from the end of surgery until successful extubation (up to 30 days)
To evaluate the association between intraoperative PCO₂ gap and arterial lactate levels and the duration of mechanical ventilation following cardiac surgery with cardiopulmonary bypass. Duration of mechanical ventilation will be measured in hours from the end of surgery until successful extubation, as documented in the patient's medical and ventilator records.
Time frame: From ICU admission after surgery until ICU discharge, up to 30 days
To evaluate the association between intraoperative PCO₂ gap and arterial lactate levels and the duration of intensive care unit (ICU) stay following cardiac surgery with cardiopulmonary bypass. ICU stay will be measured in days from ICU admission after surgery until ICU discharge, as documented in the patient's medical records.
Time frame: From the end of surgery until hospital discharge, up to 30 days
To evaluate the association between intraoperative PCO₂ gap and arterial lactate levels and the duration of hospital stay following cardiac surgery with cardiopulmonary bypass. Hospital stay will be measured in days from the end of surgery until hospital discharge, as documented in the patient's medical records.
Trial opening soon.
Get NotifiedAin Shams University
Other
Intraoperative PCO₂ Gap and Lactate Levels as Early Predictors of Postoperative Cognitive Dysfunction in Elderly Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07816081
Anesthesia, Conduction, Arterial Occlusive Diseases
Hanoi, Phuongmai, Vietnam
View Trial DetailsNCT07643194
Cognition Disorders, Cognitive Dysfunction
Beijing, Beijing Municipality, China
View Trial DetailsNCT07626567
Aortic Valve Disease, Aortic Valve Stenosis
View Trial DetailsNCT07510711
Cognition Disorders, Cognitive Dysfunction
View Trial Details